×
Nyxoah SA EBIT 2021-2024 | NYXH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Nyxoah SA ebit from 2021 to 2024. Ebit can be defined as earnings before interest and taxes.
Historical Chart (TTM)
Annual
Annual % Change
Quarterly
Quarterly - YOY Change
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$37.2B
Hims & Hers Health (HIMS)
$15B
Tempus AI (TEM)
$13.5B
Inspire Medical Systems (INSP)
$5.3B
IRhythm Technologies (IRTC)
$3.5B
Privia Health (PRVA)
$3.1B
Enovis (ENOV)
$2.5B
Clover Health Investments (CLOV)
$2.3B
Azenta (AZTA)
$2.1B
Schrodinger (SDGR)
$1.9B
Omnicell (OMCL)
$1.9B
Phreesia (PHR)
$1.7B
10x Genomics (TXG)
$1.5B
Butterfly Network (BFLY)
$1B
Talkspace (TALK)
$652M
Fulgent Genetics (FLGT)
$531M
Standard BioTools (LAB)
$517M
TruBridge (TBRG)
$426M
Health Catalyst (HCAT)
$338M
SOPHiA GENETICS SA (SOPH)
$319M
Pulmonx (LUNG)
$262M
American Well (AMWL)
$191M
EUDA Health Holdings (EUDA)
$102M
MDxHealth SA (MDXH)
$88M
P3 Health Partners (PIII)
$77M
111 (YI)
$69M
CareCloud (CCLD)
$63M
HeartBeam (BEAT)
$58M
Outset Medical (OM)
$50M
Zepp Health (ZEPP)
$45M